Pfizer requested emergency authorization for its Covid vaccine before FDA approval
Pfizer has found itself drawn into a contentious political debate about how quickly regulators in the U.S. should allow a vaccine to be given to Americans. While U.S. President Donald Trump pushed to have a shot approved before Election Day, regulators put in place rigorous standards — including two months of safety data — that largely pushed that goal out of reach.